Print

IAVI S001

Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers

Trial Details:

I Completed
IAVI; DNAVEC March 01, 2013
SeV-G,Ad35-GRIN Replicating Sendai Gag A; Ad 35 Gag-Reverse Transcriptase-Integrase-Nef (GRIN) A
SeV-G Viral Vector - Replicating
Ad35-GRIN Viral Vector - Adeno
Kenya, United Kingdom, Rwanda 64
NCT01705990
http://www.clinicaltrials.gov/ct2/show/NCT01705990?term=s001&rank=3